Early research (Phase 1)Study completedNCT03006367
What this trial is testing
Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD
Who this might be right for
Attention Deficit Disorder With Hyperactivity
Aevi Genomic Medicine, LLC, a Cerecor company 32